BridgeMD
New treatment option for Gynaecological, Urological or Rectal Cancer
Official title The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients
ClinicalTrials.gov ID: NCT06769061
What this study is testing
- What it's testing
- Objectives: To explore the feasibility and effectiveness of acupuncture on reducing Chemotherapy Induced Peripheral Neuropathy (CIPN) in gynaecological cancer patients who have received carboplatin and paclitaxel chemotherapy combination. Results of this pilot trial will provide preliminary information for a potential a larger scale multicentre study.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Age 18 or above
- Diagnosis of uterine (endometrial) cancer, ovarian cancer and cervical cancer
- ECOG=0-2
- Life expectancy of \> 6 months
- Completed at least 6 cycles of carboplatin or cisplatin chemotherapy together with paclitaxel at least 3 months before joining the study
You likely can't join if
- Bleeding tendency
- Abnormal clotting profile
- Platelet lower than 50
- Received acupuncture in the past
- Currently receiving chemotherapy treatment
- Known neurological disorders or pre-existing neuropathy unrelated to chemotherapy
See the full eligibility criteria
- Age 18 or above
- Diagnosis of uterine (endometrial) cancer, ovarian cancer and cervical cancer
- ECOG=0-2
- Life expectancy of \> 6 months
- Completed at least 6 cycles of carboplatin or cisplatin chemotherapy together with paclitaxel at least 3 months before joining the study
- Able to read and understand the questionnaires
- PNQ score of C or above
- Bleeding tendency
- Abnormal clotting profile
- Platelet lower than 50
- Received acupuncture in the past
- Currently receiving chemotherapy treatment
- Known neurological disorders or pre-existing neuropathy unrelated to chemotherapy
- Routinely take aspirin or any anticoagulant drugs
- Having active skin infection
- With pacemaker
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.